Conference Service Mandl

abstract: The use of mass spectrometry to assess the chemical structures of complex lipids as well as quantitatively determine the presence of specific lipids in biological tissues (lipidomics).

abstract: The Foundation's mission is the organization and sponsorship of international conferences, symposia, and educational programs which are dedicated to the advancement of bioorganic and medicinal chemistry.

abstract: There have been significant advances in our understanding of the causes and pathologic progression of neurodegenerative diseases. Identification of disease-causing mutations has provided unprecedented opportunities to develop new and predictive models and move closer to new therapeutic treatments. Technological advances in biochemistry, genomics, proteomics and imaging have facilitated the ability to pose and answer complex questions in complex disease, as well as an appreciation that neurodegenerative diseases have distinct cell death signaling cascades that can share some common molecular events.

abstract: The functioning of the nervous system depends on formation of a complex pattern of connections during development. If these connections are subsequently lost through injury or degeneration, axons in the adult CNS fail to regenerate, creating a major clinical challenge. The last several years have seen tremendous progress in identifying molecular mechanisms for axon development and regeneration, although much remains to be learned about these complex processes. Rapid progress is being made in identifying new classes of extracellular regulators, understanding the mechanisms by which this extracellular information is transduced by the neuron into appropriate responses, and learning the underlying molecular logic for the formation of neural connectivity. This meeting will bring together researchers in the fields of axon development, degeneration and regeneration.

abstract: The goal of this Keystone meeting is to bring together both pioneers and newcomers to the neurobiology of the chemical senses to discuss the development and function of neuronal circuits that underlie the perception of odorants, tastants, and pheromones. In the decade since the identification of molecular receptors for chemosensory stimuli, the field is increasingly moving toward questions of how sensory circuits are assembled during development and how they function in mediating chemosensory perception. Researchers are elucidating the molecules and mechanisms that pattern connections from the periphery to the brain. Using electrophysiological and imaging techniques, information processing is being studied mostly at the periphery. However, there is little information about how information is propagated from lower pathways to the cortex (or equivalent) and other higher brain regions.

abstract: Welcome to the Nucleic Acid Diagnostics & Therapeutics Summit. This inaugural summit will be be held in Boston, MA immediately prior to the annual RNAi World Congress, which will address the latest research in RNAi and microRNA research. In contrast the DxRx Summit will be attended by investors, corporate management, business leaders, legal & regulatory advisors, clinical trial CROs and others who are interested in the diagnostic and therapeutic applications of DNA, RNAi, microRNAs, and antisense technology. Registered delegates will also be eligible to attend a half-day interactive business tutorial on the market and business landscape for diagnostics and therapeutics based on RNAi and microRNAs hosted by Enal Razvi, PhD. Agenda Topics to include: Reviews of Company Pipelines Clinical Trial Status of Nucleic Acid-Based Therapeutics Patent Status of Nucleic Acid-Based Diagnostics and Therapeutics Nucleic Acid Drug Delivery microRNAs as Diagnostics and Therapeutic Entities Nucleic Acid Biomarkers for Personalized Medicine Reimbursement and Regulatory Landscape Investor Attitudes to this Sector Emerging Company Showcase Confirmed Speakers: Dr Patrick Y. Lu, President and CEO, Sirnaomics Dr Dmitry Samarsky, VP Technology Development, RXi Pharmaceuticals Dr James Hamilton, CEO, Calando Pharmaceuticals Prof James G Patton, Vanderbilt University Jeffery Vick, CEO, Silence Therapeutics Dr Nobuyoshi Kosaka, National Cancer Center Research Institute, Tokyo Dr Nicolay Ferrari, Director of Pharmacology, Topigen Dr Søren Tulstrup, CEO, Santaris Pharma Dr William Marshall, President and CEO, Miragen Therapeutics

abstract: The Society of Toxicology (SOT) Annual Meeting is the largest toxicology meeting and exhibition in the world, attracting approximately 6,500 scientists from industry, academia, and government. The program includes a plenary and other special lectures, symposia, workshops, roundtable discussions, and platform and poster presentations. The meeting also offers continuing education courses ranging from basic to advanced levels. In addition, the Society presents annual awards to recognize outstanding achievements in toxicology.

abstract: The main goal of the Gordon Research Conference (GRC) on Carbohydrates is to bring together a diverse group of scientists who work in the broad area of glycoscience (carbohydrate chemistry, carbohydrate biochemistry, and glycobiology) to discuss recent progress and future challenges in the field.

abstract: The conference will highlight a state-of-the-art view of research in plant molecular biology. In addition to keynote addresses and invited symposia, individuals are invited to submit abstracts for presentation as talks in concurrent sessions, or as posters. Ample time will be set aside for discussion at various workshops.